We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
17:00 - 18:00
K2
Lung cancer 1
Pervin Hurmuz, Turkey;
Petra Jankowska,
Poster Discussions
Clinical
17:00 - 18:00
Safety of SBRT in centrally and ultra-centrally located lung tumours: A PRISMA-based systematic review and meta-analysis
Shari Wiegreffe, Germany
-3854
17:00 - 18:00
Intensity modulated proton radiotherapy for thymoma patients: NTCP model-based selection and first results.
Robin Wijsman, The Netherlands
-3207
17:00 - 18:00
Cardiological findings and their clinical consequences after pre-treatment echocardiographic screening in thoracic radiotherapy patients
Umut Fidan, The Netherlands
-2690
17:00 - 18:00
High-dose consolidative thoracic radiotherapy in advanced NSCLC with favorable response after first-line systemic therapy with ICIs
Federico Colombo, Italy
-2343
17:00 - 18:00
Survival of LD-SCLC patients followed with brain-MRI instead of the prophylactic cranial irradiation (PCI) - results of a prospective one-arm study
Ewa Wasilewska-Tesluk, Poland
-3715
17:00 - 18:00
Prognostic significance of baseline [18F]-FDG vs. [18F]-FAPI PET/CT parameters in advanced and recurrent lung cancer
Kira Vordermark, Germany
-719
17:00 - 18:00
Image-based analysis of dose-survival associations in lung radiotherapy following heart dose limit implementation within the RAPID-RT study
Tom Marchant, United Kingdom
-2954
17:00 - 18:00
Multi-omics integrative modelling for SBRT in early-stage NSCLC: report on the first 194 patients of the MONDRIAN study (NCT05974475)
Stefania Volpe, Italy
-4614
17:00 - 18:00
The role of thoracic radiotherapy in ES - SCLC in ICI era: preliminary results of STHORI trial
Giulia Lezzi, Italy
-3901